CRIS Projects Details -
Accept Cookies

Cookies: How we use information on our website:

We use cookies on our website to make it clear, useful and reliable. In order to achieve this and to provide certain personalised features we store a small amount
of data about you. Click Here to learn more. By navigating from the front page to other sections of our website, you are consenting to information being stored.


CRIS Projects Details

Project Details

 

Validation of a novel Anticholinergic effect on cognition scale (V-AEC)

Lead Applicant Name :
Christoph Mueller
Project Type :
Research
Approval Date :
06-Oct-2016
References :
Bishara D, Perera G, Harwood D, Taylor D, Sauer J, Funnell N, Gee S, Stewart R, Mueller C. (2021) Centrally- acting anticholinergic drugs-associations with mortality, hospitalisation and cognitive decline following dementia diagnosis in people receiving antidepressant and antipsychotic drugs. Aging and Mental Health.<br/><br/>Bishara D, Perera G, Harwood D, Taylor D, Sauer J, Funnell N, Stewart R, Mueller C. (2021) Centrally Acting Anticholinergic Drugs Used for Urinary Conditions Associated with worse outcomes in dementia. Journal of the American Medical Directors Association.
Lay Summary :
Anticholinergic drugs are commonly used in older people to treat conditions like urinary incontinence, depression, and heart or lung problems. Research has shown that these can worsen dementia or are associated with a higher risk of death. The aim of this study is to investigate the use of anticholinergic medication in people presenting to dementia assessment services and how good a new scale might predict adverse outcomes.<br/>

< Back to search